In vivo inhibition of low density lipoprotein receptor-related protein improves survival of factor VIII in the absence of von Willebrand factor.
Turecek
P L
PL
Schwarz
H P
HP
Binder
B R
BR
D000818:Animals; D002352:Carrier Proteins / Q000494:pharmacology*; D005169:Factor VIII / Q000378:metabolism*; D005982:Glutathione Transferase / Q000494:pharmacology*; D006801:Humans; D007700:Kinetics; D026503:Low Density Lipoprotein Receptor-Related Protein-1; D051379:Mice; D018345:Mice, Knockout; D011971:Receptors, Immunologic / Q000037:antagonists & inhibitors*; D011973:Receptors, LDL / Q000037:antagonists & inhibitors; D011993:Recombinant Fusion Proteins / Q000494:pharmacology; D011994:Recombinant Proteins / Q000378:metabolism; D014842:von Willebrand Diseases / Q000235:genetics / Q000503:physiopathology; D014841:von Willebrand Factor / Q000235:genetics / Q000378:metabolism*
D002352:Carrier Proteins; D026503:Low Density Lipoprotein Receptor-Related Protein-1; D011971:Receptors, Immunologic; D011973:Receptors, LDL; D011993:Recombinant Fusion Proteins; D011994:Recombinant Proteins; D014841:von Willebrand Factor; D005169:Factor VIII; C103332:GST-RAP protein, recombinant; D005982:Glutathione Transferase